A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease
NCT07630883 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-06-05
Summary
Micro and nanoplastics (MNPs) are environmental contaminants found in food and water. Recent evidence suggests these particles may be linked to intestinal inflammation and changes in gut bacteria, which are key features of Crohn's Disease (CD). This study aims to investigate if patients with Crohn's Disease have a reduced ability to clear these plastic particles and how this affects their immune system and intestinal health.
Conditions
- Crohn's Disease (CD)
Sponsors & Collaborators
-
Mak Wing Yan
lead OTHER
Principal Investigators
-
Joyce Wing Yan Mak · Chinese University of Hong Kong
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-15
- Primary Completion
- 2031-06-30
- Completion
- 2031-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Biologics and Partial Enteral Nutrition Study
NCT04859088 ·Status: RECRUITING ·Phase: NA
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461 ·Status: RECRUITING ·Phase: PHASE2
-
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
NCT06001450 ·Status: RECRUITING
-
Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease
NCT00291668 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Soluble Dietary Fiber on Bacterial Translocation in Crohn's Disease
NCT02164877 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
NCT06581328 ·Status: RECRUITING ·Phase: PHASE4
-
Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery
NCT06146335 ·Status: COMPLETED ·Phase: NA
-
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
NCT07504510 ·Status: RECRUITING
-
Whole-Food, Plant-Based Diet for Active Crohn's Disease
NCT04982666 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy
NCT02793778 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease
NCT04305535 ·Status: UNKNOWN ·Phase: NA
-
A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease
NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
NCT00152490 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease
NCT07344428 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease
NCT07010926 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients
NCT04065048 ·Status: COMPLETED ·Phase: NA
-
Microflora and Metabolomics of Crohn's Disease Patients
NCT04965584 ·Status: UNKNOWN
-
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
NCT04102111 ·Status: TERMINATED ·Phase: PHASE2
-
CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease
NCT03171246 ·Status: COMPLETED ·Phase: NA
-
Semi-elemental Versus Polymeric EEN in the Preoperative Optimization for Patients with CD
NCT06587178 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921 ·Status: COMPLETED ·Phase: PHASE2
-
Triple Combination Therapy in High Risk Crohn's Disease (CD)
NCT02764762 ·Status: COMPLETED ·Phase: PHASE4
-
Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment
NCT02622763 ·Status: TERMINATED ·Phase: PHASE1
-
Fecal Microbial Transplantation in Patients With Crohn's Disease
NCT03267238 ·Status: COMPLETED ·Phase: EARLY_PHASE1